Annual report pursuant to Section 13 and 15(d)

Stockholders' equity

v2.4.1.9
Stockholders' equity
12 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Shareholders' equity
Stockholders’ equity
Common Stock
In 2014 and 2013 the Company raised additional funds through the offering and private placements of common stock to a limited number of accredited investors. In connection with the 2014 public offering, the Company sold an aggregate of 647,706 shares of common stock at a purchase price of $4.75 per share. In connection with this public offering the Company incurred commissions, legal fees and various other costs of $742,710 which were offset against the proceeds in additional paid in capital, resulting in net cash proceeds of $2,333,894. In connection with the 2014 and 2013 private placements the Company sold an aggregate of 1,400 and 1,476,789 shares of common stock at a purchase price $4.50 per share, resulting in net cash proceeds of $6,300 and $5,966,805.
The holders of Common Stock have the right to vote their interest on a per share basis. At December 31, 2014 and 2013 there were 15,905,881 and 15,155,200 shares of Common Stock outstanding, respectively.
Preferred Stock
On February 13, 2013, the Company authorized preferred stock of 10 million shares, at December 31, 2014 none of these shares were issued or outstanding.
Stock-Based Compensation
In 2006, the Company adopted the 2006 Stock Option and Incentive Plan (the “Plan”), under which the board of directors may grant incentive or non-qualified stock options and stock grants to key employees, directors, advisors and consultants of the Company. The Plan was amended at various dates by the board to increase the reserved shares of common stock issuable under the Plan to 3,838,750 as of December 31, 2014 (the “Amended Plan”).
Stock options vest based upon the terms within the individual option grants, with an acceleration of the unvested portion of such options upon a change in control event, as defined in the Amended Plan. The options are not transferable except by will or domestic relations order. The option price per share under the Amended Plan cannot be less than the fair market value of the underlying shares on the date of the grant. The number of shares remaining available for future issuance under the Amended Plan as of December 31, 2014 and 2013 was 1,748,783 and 58,683, respectively.
In 2013, the Company granted nonqualified options to purchase an aggregate of 37,500 and 39,000 shares of common stock at $3.20 and $4.50 per share, respectively to certain employees. These options have a vesting schedule of four years and expire in ten years. The fair value of the options issued in 2013 was $80,952. The weighted-average grant date fair value of stock options granted during 2013 was $0.75 and $1.35 per option.
In 2014, the Company granted nonqualified options to purchase an aggregate of 318,325 shares of common stock for between $4.50 and $5.39 per share, respectively to certain employees, a director, and a consultant. These options have a vesting schedule of four years and expire in ten years. One of the grants for 100,000 shares had vesting terms of one year and only vest if the Company achieves positive earnings before interest taxes depreciation and amortization adjusted for stock compensation. The fair value of the options issued in 2014 was $577,029. The weighted-average grant date fair value of stock options granted during 2014 was $1.89 per option.
Stock option activity for the year ended December 31, 2014 was as follows:
Common Stock Options
Number of
Options
 
Exercise
Price
Per
Share
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding, December 31, 2013
1,148,000

 
$1.20-$4.50

 
$
2.13

 
5.80 years
 
$
2,721,100

Granted
318,325

 
$4.50-$5.39
 
4.85

 
 
 
 

Exercised
(101,575
)
 
$1.20-$2.60

 
1.59

 
 
 
 

Canceled and forfeited
(8,425
)
 
$0.12-$4.50

 
3.52

 
 
 
 

Expired

 

 

 
 
 
 

Outstanding, December 31, 2014
1,356,325

 
$1.20-$5.39

 
$
2.77

 
5.12 years
 
$
3,618,935

Exercisable, December 31, 2014
863,552

 
 

 
$
2.65

 
 
 
$
2,287,760

Vested and expected to vest, December 31, 2014
1,356,325

 
 

 
$
2.77

 
 
 
$
3,618,935


The Company does not expect any forfeitures and the table above represents all stock options expected to vest. The Company uses the Black-Scholes option pricing model to determine the fair value of stock options granted. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. Expected volatility was calculated based on the average volatility of four comparable publicly traded companies. The average expected life was estimated using the simplified method to determine the expected life based on the vesting period and contractual terms, since it does not have the necessary historical exercise data to determine an expected life for stock options. The Company uses a single weighted-average expected life to value option awards and recognizes compensation on a straight-line basis over the requisite service period for each separately vesting portion of the awards. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term which approximates the expected life assumed at the date of grant.
The weighted average assumptions used in the Black-Scholes option pricing model for options granted in 2014 and 2013 are as follows:
Stock option awards:
2014
 
2013
Expected life
6.25 years
 
5.63 years
Risk-free interest rate
1.51%
 
1.34%
Expected volatility
22.7%-32.3%
 
26.5%-36.1%

The Company has granted restricted stock awards to its employees and directors. The performance based awards have vesting schedules ranging from 100% 90 days after an initial public offering (IPO) up to 100% one year after an IPO.
Restricted stock activity for the years ended December 31, 2014 was as follows: 
 
Number of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value
Unvested, December 31, 2013
361,570

 
$
1.31

Granted

 

Vested
(205,720
)
 
1.36

Forfeited
7,500

 
2.60

Unvested, December 31, 2014
163,350

 
$
1.31


During the years ended December 31, 2014 and 2013, the Company recognized stock-based compensation of $117,138 and $59,678, respectively, related to the issuance of stock options and restricted stock. No tax benefit was recognized related to the stock-based compensation recorded during the years. At December 31, 2014 and 2013, the total compensation cost related to unvested restricted stock awards and stock option awards not yet recognized is $156,179 and $124,845, respectively. This amount will be recognized over a weighted average period of 0.56 years.
Stock Based Compensation - Ilios
In 2009, Ilios adopted the 2009 Stock Incentive Plan (the “2009 Plan”) under which the board of directors may grant incentive or non-qualified stock options and stock grants to key employees, directors, advisors and consultants of the company. The maximum number of shares allowable for issuance under the Plan is 2,000,000 shares of common stock.
Stock options vest based upon the terms within the individual option grants, with an acceleration of the unvested portion of such options upon a change in control event, as defined in the Plan. The options are not transferable except by will or domestic relations order. The option price per share under the Plan cannot be less than the fair market value of the underlying shares on the date of the grant.
During the years ended December 31, 2014 and 2013 Ilios recognized stock-based compensation of $9,798 and $(41,311), related to the forfeiture and issuance of stock options and restricted stock, respectively. No tax benefit was recognized related to the stock-based compensation recorded during the year. At December 31, 2014 and 2013 there were 310,000 unvested shares of restricted stock outstanding. At December 31, 2014 and 2013 the total compensation cost related to unvested restricted stock awards and stock option awards not yet recognized is $14,478 and $9,004, respectively. This amount will be recognized over the weighted average period of 1.24 years.
Stock option activity relating to Ilios for the years ended December 31, 2014 was as follows: 
Common Stock Options
Number of
Options
 
Exercise
Price
Per
Share
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding, December 31, 2013
575,000

 
$0.10-$0.50

 
$
0.29

 
6.44 years
 
$
120,000

Granted
100,000

 
0.50

 
0.50

 
 
 
 

Exercised

 

 

 
 
 
 

Canceled and forfeited

 

 

 
 
 
 

Expired

 

 

 
 
 
 

Outstanding, December 31, 2014
675,000

 
$0.10-$0.50

 
$
0.32

 
6.56 years
 
$
120,000

Exercisable, December 31, 2014
193,750

 
 

 
$
0.50

 
 
 
$

Vested and expected to vest, December 31, 2014
675,000

 
 

 
$
0.32

 
 
 
$
120,000


Ilios does not expect any forfeitures and the table above represents all stock options expected to vest. Ilios uses the Black-Scholes option pricing model to determine the fair value of stock options granted. Expected volatility was calculated based on the average volatility of comparable publicly traded companies, the expected life of the options was calculated using the simplified method, and the risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term which approximates the expected life assumed at the date of grant. The Company uses a single weighted-average expected life to value option awards and recognizes compensation on a straight-line basis over the requisite service period for each separately vesting portion of the awards.
For the Ilios awards noting none made in 2013, the weighted average assumptions used in the Black-Scholes option pricing model for options granted in 2014 are as follows:
Stock option awards:
 
Expected life
6.25 years
Risk-free interest rate
1.65%
Expected volatility
35.2%

Ilios has granted restricted stock awards to its employees and directors. The awards have only service conditions and carry vesting schedules ranging from 100% 90 days after an IPO up to 100% one year after an IPO.
Restricted stock activity for the Ilios awards, for the years ended December 31, 2014 was as follows: 
 
Number of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value
Unvested, December 31, 2013
310,000

 
$
0.10

Granted

 

Vested

 

Forfeited

 

Unvested, December 31, 2014
310,000

 
$
0.10